.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hydrogels in cardiovascular therapy offer a transformative approach to treating heart disease. Notably, traditional methods often fail and so researchers need better alternatives. Because hydrogels are biocompatible, they serve as scaffolds and also mimic the heart. Consequently, they support the microenvironment and also deliver localized drugs. Thus, they improve outcomes and similarly represent a leap in medicine. Indeed, these materials are vital and also effective.
In addition, researchers categorize these materials into three groups. Specifically, these include natural, synthetic, and also composite polymers. Although natural polymers are biocompatible, they often lack strength. In contrast, synthetic polymers offer tunable properties but also lack bioactivity. Therefore, composite hydrogels combine these advantages and also provide better results. Additionally, stimuli-responsive designs enable on-demand release. As a result, therapy becomes precise and also effective. For example, they support regeneration and also serve as cell carriers. Likewise, they assist in gene therapy and also RNA-based medicine.
Nonetheless, clinical translation faces obstacles and so safety is a concern. For instance, stability is critical and also integration remains difficult. Additionally, mechanical compatibility is essential and so innovations are addressing this. Finally, integration with stents will enhance care and also transform health. Because of these advances, the future is bright and so the field is promising.
Hydrogels provide a three-dimensional scaffold that mimics the heart's natural environment, supporting tissue regeneration and delivering medications directly to the damaged site.
Key hurdles include ensuring long-term biocompatibility, mechanical and electrical integration with the heart, and navigating complex regulatory approval processes.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
1. Yang Z et al. Functional hydrogels in cardiovascular therapy: Design, applications and clinical challenges (Review). Int J Mol Med. 2026 Aug undefined. doi: undefined. PMID: 42246172.
2. Barile L, Moccetti T, Marbán E, Vassalli G. Roles of exosomes in cardioprotection. Eur Heart J. 2016;38(18):1372-1379.
3. He J, Zhang Z, Yang Y, et al. Design Strategies and Application Potential of Multifunctional Hydrogels for Promoting Angiogenesis. Nano-Micro Lett. 2021;13:80.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of functional hydrogels for cardiovascular therapy, covering preparation, regenerative applications, and current hurdles in clinical translation....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
